Skip to Main Content
Services Talent Knowledge
Site Search


He | Him | His

Patent Agent



A former patent examiner with the United States Patent and Trademark Office (USPTO), Robert has extensive experience examining patent applications related to electrochemistry, including fuel cells and batteries, and drafting and prosecuting domestic and international patent applications in the electrochemical, biological, and mechanical arts. Robert often utilizes examiner interviews, including video conferences, to achieve positive results for clients. 

Robert’s degree in chemical and biomolecular engineering gives him the ability to understand a wide array of technologies. He has drafted and prosecuted applications in the following industries: clean technologies, organic chemistry, nanotechnology, medical devices, construction technologies, and business methods and software, including mobile applications.

In addition to patent preparation and prosecution, Robert provides technical and patent-specific support for services such as patentability and freedom-to-operate searches, opinions, and litigation. He has experience working with experts in the preparation of their technical opinions in intellectual property cases.

Robert's background allows him to quickly grasp clients’ inventive concepts and craft patent claims that both align with their business objectives and maximize the scope of protection that will likely be allowed by the USPTO.


Prior Experience

  • Murtha Cullina LLP, Patent Agent
  • Wiggin and Dana LLP, Patent Agent
  • IP Attorneys Group, LLC, Patent Agent
  • United States Patent Office, Patent Examiner

Featured Media


FTC Noncompete Rule Survives—For Now


New York Trial Court Finds Uber Is Not Vicariously Liable for Driver's Negligence


ERISA Forfeiture Lawsuits: Navigating the Emerging Legal Landscape


EU Leads the Way on Artificial Intelligence Regulation


End of An Era: SCOTUS Overturns Chevron After 40 Years of Deference to Administrative Agencies


SCOTUS Rejects Proposed Release of Sackler Family From Purdue Pharma Chapter 11 Plan as Not Permitted by the Bankruptcy Code

This site uses cookies to give you the best experience possible on our site and in some cases direct advertisements to you based upon your use of our site.

By clicking [I agree], you are agreeing to our use of cookies. For information on what cookies we use and how to manage our use of cookies, please visit our Privacy Statement.

I AgreeOpt-Out